TRIBUNNEWS.COM, JAKARTA - - Kaka Slank dikenal sebagai vokalis sukses bersama grup bandnya, yang kini sudah berusia 41 tahun. Gaya Rock n roll Kaka di atas panggung mampu menyihir ribuan penonton ...

Now a stay-at-home dad, Tim finds out that his daughter Tina is an undercover agent boss baby, whose mission is to thwart the world domination plans of the headmaster of her older sister's school.

Umat Kristiani membuat pohon Natal setinggi mencapai 7 meter dengan hiasan ratusan pasang sandal jepit yang disumbangkan oleh warga sekitar. tentu saja, penggunaan sandal jepit sebagai hiasan pohon ...

Seven-year-old Tim Templeton finds that his new baby brother has been sent to save the world from a dastardly scheme cooked up by the CEO of Puppy Company. Show more Seven-year-old Tim Templeton's ...

Merck's DOR/ISL regimen demonstrated non-inferiority to bART and BIC/FTC/TAF in two pivotal Phase 3 trials for adults with HIV-1. Both trials achieved primary safety objectives, with detailed ...

KANSAS CITY, Mo. — Kansas State basketball coach Jerome Tang is the first to admit that his relationship with Dug McDaniel remains a work in progress. The two haven't always seen eye-to-eye ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion. Under the terms of the deal, the company will gain the exclusive global ...

Merck (NYSE:MRK) and Chinese biopharmaceutical company Hansoh Pharma (OTCPK:HNSPF) announced a global licensing deal on Wednesday to develop HS-10535, an oral GLP-1 receptor agonist targeted at ...

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...

The Icons section highlights Shanghai Tang's most emblematic pieces, including bespoke creations for Nicole Kidman, Lin Chi-ling, and Richie Jen. When David Tang launched his brand Shanghai Tang ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...